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Abstract: (1) Background: Despite cleft lips and palates belonging to the most common orofacial
congenital anomalies, their morphopathogenesis is not yet fully understood. The study aimed to
determine the distribution and relation of cytokines interferon-γ (IFN-γ), tumor necrosis factor-
alpha (TNF-α), interleukin (IL)-2, IL-7, IL-12, and IL-13 in the cleft affected mucosa of the lip.
(2) Materials and Methods: Twenty cleft lip (CL) mucosal samples and seven control tissues of oral
cavity mucosa were included in the study. Specimen were obtained during reconstruction surgeries
and processed by hematoxylin and eosin staining and immunohistochemistry for IFN-γ, TNF-α,
IL-2, IL-7, IL-12, and IL-13. (3) Results: The distribution of cytokines was higher overall in the cleft
affected epithelium compared to the connective tissue, with TNF-a, IL-2, and IL-12 displaying the
highest number of immunopositive cells. With the exception of IL-2, CL specimen showed higher
immunoreactivity. IFN-γ displayed only minor immunoreactivity, with no expression in the control
epithelium. Correlation analysis was strongest between CL epithelial IL-13 and IFN-γ (z = 0.71,
p < 0.0001). (4) Conclusions: The CLP affected epithelium displays high degrees of plasticity in
expressing different cytokines, pointing towards the stimulation of a local adaptive immune response
based on consistent inflammatory processes.
Keywords: immunohistochemistry; cytokines; children; cleft lip
1. Introduction
Orofacial clefts encompass a large group of congenital deformations with structural
defects in the oral cavity and the adjacent facial framework. Within this group, the most
common anomalies are cleft lips and palates (CLP), either occurring in isolation, in com-
bined form, or as a part of an array of malformations [1]. The prevalence of CLP differs
based on ethnicity, race, geographic location, and socioeconomic status [2], with 1.55 cases
per 1000 live births in Europe [3].
A multifactorial model has been proposed for the development of CLP, though recent
studies examining concordance rate and heritability between monozygotic twins with CLP
pointed towards a strong genetic component within the multifactorial pattern [2]. The
majority of CLP patients are subject to the non-syndromic form, where cleft lip and/or
palate occur in the absence of other congenital anomalies. The less common syndromic
form is associated with other deformations primarily backtracked to chromosomal or
monogenic syndromes [1].
CLP affected patients suffer notably from a high degree of morbidity including im-
paired feeding, speech and language development, combined with restricted facial growth.
A multidisciplinary management approach including repeated surgical interventions is
required to restore their function and to improve the child’s facial appearance [2].
Oral health in postnatal CLP patients has been considered the major factor influencing
a successful surgical outcome. The oral health in the CLP group has previously been
evaluated with regards to the presence and degree of tooth decay, dental plaques, and
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gingival inflammation [4]. Reports on the oral microflora in CLP subjects described a higher
grade of gingivitis in CLP patients when compared to a healthy control group, despite
no observed difference in the degree of bacterial colonization [5]. While significantly
higher gingival inflammation is reported in multiple studies, a precise identification and
quantification of tissue mediators has not been subject to extensive research yet.
Interleukins and interferons have been described in the context of hyperplastic scar
formation in the postoperative CLP patient [6] and in tissue remodeling during the chronic
inflammatory state of gingivitis [7], making them of particular interest in postnatal CLP
morphology. The interplay of the various cytokines and their correspondent immunoregu-
latory cells [8–10] can be visualized in a simplified form in Figure 1.
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A plethora of cytokines has been implicated in the developme t and progression of
oral cavity diseases, among them tumor necrosis factor-alpha (TNF-α). The pleotropic
cytokine is secreted by an array of cells, namely macrophages, T cells, Langerhans cells,
mast cells and keratinocytes [11]. A wide range of biological effects has been attributed
to TNF-α, among them the inhibition of proliferation and stimulation of differentiation of
keratinocytes. With the ability of keratinocytes to secrete T F-α, research in the past decade
pointed tow rds TNF-α as a key regulatory factor in the pathoge esis of oral lichen planus
and periodontitis [12]. Elevated levels were depicted in local lesions of these diseases,
contrary to the normal mucosa where the cytokine was nearly undetectable [13]. Along with
oral inflammatory pathologies, the increased secretion of TNF-α by keratinocytes has also
been reported in the state of dysplastic and neoplastic oral lesions [14]. Apart from tissue
remodeling, increased serum levels of TNF-a have been ssociated with the development
and progression of neuropathic pain, adding towar s the considerable morbidity of cleft
affected patients [15].
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Interleukin (IL)-2, primarily produced by T helper-1 (Th-1) cells, is commonly known
for the induction of proliferation and differentiation of T and B cells. Furthermore, the
cytokine is involved in the activation of both natural killer (NK) cells and monocytes [16].
While oral mucosa keratinocytes demonstrate the presence of most pro-inflammatory
cytokines (IL-1, IL-6, IL-8, TNF-α) even in a healthy state, IL-2 is not readily expressed
in the normal mucosa [17,18]. Elevated IL-2 levels, however, were detected in patients
with a history of recurrent aphthous stomatitis lesions. These findings were coherent with
the cell mediated immune response provoked by IL-2. It should be noted that the same
study, proving increased secretion of IL-2 in recurrent aphthous lesions, observed higher
resting levels of previously mentioned pro-inflammatory cytokines and IL-2 in lesioned
and non-lesioned mucosa of the affected patients compared to healthy subjects [19].
IL-7 is mainly produced by stromal cells in lymphoid organs and bone marrow, as
well as keratinocytes and epithelial cells [20]. Like IL-2, it drives the development of T
and B cells and is involved in the survival of naive and memory T cells. Besides its role
in lymph node organogenesis, IL-7 and its receptor chains are expressed on lymphatic
endothelial cells in dermal lymphatics. During acute and chronic skin inflammation, mice
with an endothelial-specific deletion of IL-7 receptor alpha chain developed more edema
compared to controls due to impaired lymphatic drainage [21]. An association between
elevated IL-7 levels and Sjögren syndrome was observed in mice. Positively regulated by
interferon-gamma (IFN-γ) producing Th-1 and CD8+ T cells in the salivary glands, IL-7
enhanced the expression of CXCR3 ligands in a T cell and IFN-γ dependent fashion and
increased the level of TNF-α, facilitating tissue destruction and inflammation [22]. Sjögren’s
syndrome is a chronic inflammatory autoimmune mediated condition of predominantly
lacrimal glands with the histopathologic hallmark feature of localized lymphomononuclear
infiltration of exocrine glandular tissue [23].
First described in 1980 [24], IL-12 was assigned a crucial role in the regulation of the
adaptive immune response, promoting naive T-cell differentiation into Th1 cells, as well as
the activation of NK and T-cells through IL-12, which in turn stimulates the production of
other cytokines, primarily IFN-γ and TNF-α [25]. Release of IL-12 has been implicated in
the initiation and progression of oral mucosa inflammatory pathologies. Most prominent
is the association between IL, gingivitis, and periodontitis. Increased levels of IL-12 in
the gingival mucosa of periodontitis affected samples were related to the severity of
inflammation and bone destruction in tissue [26]. Another study demonstrated a co-
occurrence of both elevated IL-12 and TNF-α in local lesions of gingivitis and chronic
periodontitis compared to periodontal healthy subjects [9].
The T cell-derived type 2 cytokine IL-13 has been described in immunosurveillance,
regulation of cancer progression, and neovascularization. By binding to its two receptor
subunits, IL-13 receptor subunit alpha-1 and IL-13 receptor subunit alpha-2 (IL-13Ra2),
downstream signaling cascades (involved in cell proliferation), cytostatic effects, or neo-
plastic cell death, are stimulated [27]. IL-13Ra2 overexpression and high affinity binding
of IL-13 were detected in human head and neck cancers [28]. In the chronic inflammatory
condition of reticular oral lichen planus, IL-13 mRNA levels were increased compared to
healthy control tissue specimens [29].
The pro-inflammatory cytokine IFN-γ is predominantly secreted by activated T cells
and NK cells, influencing a variety of biological processes such as macrophage activation,
antigen presentation enhancement, immunity mediation, and the regulation of Th-1/Th-
2 balance [30]. In head and neck squamous cell cancers, an IFN-γ mediated increase
in apoptosis, inhibition of cancer cell viability, and cell migration was observed [31].
The expression of IFN-γ induced chemokines by epidermal keratinocytes is enhanced in
dermatoses like psoriasis and atopic dermatitis [32].
Life 2021, 11, 556 4 of 14
Due to the influence of cytokines in a variety of oral inflammatory pathologies,
this research aimed to identify the extent of distribution and spatial relationship of pro-
inflammatory and immunoregulatory cytokines in the mucosal tissue of the cleft lip (CL).
2. Materials and Methods
2.1. Study Participants
The patient group included twenty cleft affected children, fourteen boys and six
girls, in the age range from 3 to 18 months (Median = 4; IQR = 3–5). Two patients were
affected with bilateral CLP, five with unilateral right-sided CLP and thirteen with unilateral
left-sided CLP. Tissue samples of the lip were obtained during lip plastic reconstruction
surgeries, correcting the state of the cleft in the CLP Centre at the Institute of Stomatology
of Riga Stradinš University. Reconstructive surgery was the definitive and sole treatment
for all included patients. The soft tissue control group (CG) encompassed seven samples,
five female and two male samples. All tissue controls were obtained during hyperdentia
correctional surgery from erupted teeth. Control tissues contained oral cavity mucosa with
underlying connective tissue. There was no evidence of any other pathologies in the tissue
control samples.
The study was independently reviewed and approved by the local Ethical Committee
of Riga Stradinš University (2003; 2013; 2018), and written informed consent was obtained
from all parents after the explanation of the nature of this study. The study was performed
in accordance with the Declaration of Helsinki, 2000.
2.2. Hematoxylin & Eosin Stain (H&E) and Immunohistochemistry (IHC)
Tissues were fixed for one day in a mixture of 2% formaldehyde and 0.2% picric
acid in 0.1 M phosphate buffer (pH 7.2). Afterwards, tissues were rinsed in thyroid
buffer containing 10% saccharose for 12 h. Samples were embedded into paraffin. Three
micrometer thick sections were cut and stained with hematoxylin and eosin (H&E) for
subsequent evaluation.
The HiDef Detection HRP Polymer system (Cell MARQUE) was used for the detection
of IFN-γ (code ab218426, rabbit polyclonal antibody, working dilution 1:500, Abcam, Cam-
bridge, UK), TNF-α (code ab6671, rabbit polyclonal antibody, working dilution 1:200, Abcam,
Cambridge, UK), IL-2 (code ab92381, rabbit monoclonal antibody, working dilution: 1:250,
Abcam, Cambridge, UK), IL-7 (code orb13506, rabbit polyclonal antibody, working dilution
1:100, Biorbyt, St. Louis, MO, US), IL-12 (code ab10894, rabbit polyclonal antibody, working
dilution 1:200, Biorbyt, St. Louis, MO, US). IL-13 (code ob10895, rabbit polyclonal antibody,
working dilution 1:200, Biorbyt, St. Louis, MO, US), and anti-macrophage inflammatory
protein 1 beta (MIP-1ß) (ab9675, working dilution 1:100, Abcam, Cambridge, UK).
2.3. Visualization and Statistical Analysis
The specimens were analyzed using light microscopy with grading of immunoreactive
structures in a semi-quantitative manner. A scale from “0” to “++++” was used for the
evaluation of epithelium and connective tissue with the following definitions: “0“—no
immunoreactive structures present in the visual field, “0/+”—occasional immunoreac-
tive structures in the visual field, “+”—few immunoreactive structures in the visual field,
“+/++”—few to moderate immunoreactive structures in the visual field, “++”—moderate
immunoreactive structures in the visual field, “++/+++”—moderate to numerous im-
munoreactive structures in the visual field,“+++”—numerous immunoreactive structures
in the visual field, “+++/++++”—numerous to abundant immunoreactive structures in the
visual field, “++++”—abundant immunoreactive structures in the visual field [33]. Images
of specimens were captured using a Leica DFC 450 digital camera.
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IBM SPSS version 22.0 was used for the statistical analysis of data. Descriptive
analysis was performed, and nonparametric Mann–Whitney U test was utilized for the
comparison of the two study groups. Spearman’s rank correlation coefficient (ρ) with
(ρ) = 0.9–1 displaying very high positive correlation, (ρ) = 0.7–0.9 high positive correlation,
(ρ) = 0.5–0.7 moderate positive correlation, (ρ) = 0.3–0.5 low positive correlation, and
(ρ) = 0.0–0.3 negligible correlation was used [34]. Results with a p-value < 0.05 were
considered statistically significant.
3. Results
The analysis of routine stained CL specimens displayed the presence of stratified
squamous epithelium and underlying connective tissue with varying degrees of chronic
inflammatory cells. Varying degrees of vacuolization were observed in the epithelium, as
well as basal cell hyperplasia and intraepithelial lymphocyte infiltration (Figure 2a,b).
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Figure 2. Hematoxylin & Eosin staining of lip mucosal tissue in two selected cases of cleft lip patients. (a) Note basal cell
hyperplasia and vacuolization in the epithelium (200×). (b) Note the predominantly inflammatory cell infiltration in the
subepithelial tissue folds (200×).
3.1. Immunohistochemistry
TNF-α distribution, both in the epithelium and connective tissue, displayed a mean
of moderate to numerous immunoreactive cells. Histopath lo ical analysis of subep-
itheli l stained cells showed primarily cells of chronic inflammatory origin, particularly
macrophages, lymp ocytes, and fibroblasts. TNF-α reactive cells in CG specimens were
less prevale t in epithelium and subepithelium (Figure 3a,b).
IL-12 in pitheliocytes and connective tissue cells was of comparabl quantity in
stained number of cells. Levels of IL-12 w re decreased in the CG, where epith lium and
underlying conn ctive tissue displayed a mean of only few to moderate immunoreactive
structures (Figure 3c,d).
A lower number of IL-2 immunoreactive cells was detected in the CL epithelium
compared to the healthy tissue. In the conn ctive tissu , positive structures for cytokine
IL-2 were higher in the CL samples than in the CG (Figure 4a,b).
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Figure 4. Immunohistochemistry micrographs of cleft affected tissue and controls. (a) Distribution of numerous IL-2
positive epitheliocytes and connective tissue cells in the cleft-affected lip mucosal tissue (IL-2, 200×). (b) Note abundant
IL-2 positive cells in the control epithelium (IL-2, 200×).
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The distribution of IL-7 in the epithelium of CL specimens varied from occasional to
numerous immunoreactive epithelial cells, whereas mainly few IL-7 positive cells were present
in the connective tissue. Both in the epithelium and connective tissue of the CG, immunoreactive
structures were less prevalent, ranging from few to few to moderate in the epithelium, and
occasional to few to moderate in the subepithelium, respectively (Figure 5a,b).
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Figure 5. Immunohistochemistry micrographs of cleft affected tissue and controls. (a) Appearance of numerous IL-7
positive epitheliocytes and few connective tissue cells in cleft affected tissue (IL-7, 200×). (b) Note few-moderate IL-7
immunoreactive epitheliocytes and few connective tissue cells in the control (IL-7, 200×).
IL-13 immunoreactive cells were detected in the range from few to numerous in the
CL epithelium, and few to moderate in the CG epithelium. The cleft group and controls
presented with a mean distribution of few to moderate IL-13 immunoreactive cells in the
connective tissue (Figure 6a,b).
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Three CL specimen displayed no IFN-γ immunoreactivity in the epithelium. The
remaining 17 samples presented with occasional to numerous immunopositive epithelio-
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distribution in the connective tissue was few to moderate (+/++) both in the CL group and
the control group (Figure 7a,b).
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Figure 7. Immunohistochemistry micrographs of cleft affected tissue and controls. (a) IFN-γ displays moderate number of
positive weakly stained epitheliocytes and connective tissue cells in a cleft affected tissue (IFN-γ, 200×). (b) Lack of IFN- γ
immunoreactive cells in the epithelium, but a moderate number of them in the connective tissue of control (IFN-γ, 200×).
Overall, analyzing the marker distribution in the CL specimen, IL-2 and IL-12 showed
the highest mean number of immunoreactive cells both in the epithelium and connective
tissue, while IFN-γ showed the lowest (Table 1).
Table 1. Distribution of immunoreactive cells in the epithelium and connective tissue of cleft lip affected specimens. Mean
distribution of immunoreactive cells in control samples.
Cleft Affected Group
TNF-α IL-12 IL-2 IL-13 IL-7 IFN-γ
Subjects EP CT EP CT EP CT EP CT EP CT EP CT
1. +++ ++ +++ +++ +++ ++ +++ ++ ++ 0/+ ++/+++ ++
2. + + +++ +/++ +++ + +++ + +++ + ++/+++ +/++
3. +/++ 0/+ ++/+++ 0/+ + 0/+ 0/+ 0/+ ++/+++ + +/++ +
4. + ++/+++ +/+++ ++ +++ ++ ++/+++ +/++ ++ + ++/+++ ++
5. ++ +++/++++ + +++ +/++ ++/+++ 0/+ +/++ +/++ + 0 ++
6. +++ +++ +++ +++ +++ +++ ++/+++ +/++ +++ +/++ +/++ +/++
7. +++ +++/++++ ++ +/++ +++ ++/+++ 0 +/++ ++ +/++ +/++ +/++
8. +++ +++ +++ +++ +++ +++ ++/+++ +/++ ++ + + 0/+
9. +++ +++ +++ ++/+++ +++ ++/+++ +/++ +/++ +++ ++ 0 +/++
10. ++/+++ ++/+++ +++ +++/++++ +++ +++ 0/+ ++/+++ 0/+ 0/+ 0/+ 0/+
11. +/++ + ++/+++ ++ +/+ + 0 +/+ ++/ + + + +/++
12. +++ ++ +++ +++ +++ +++ +++ +/++ +++ + +++ +/++
13. 0/+ /++ +/++ ++ + 0 0/+ +/++ 0/+ 0 0/+
14. ++/+++ +++ ++/+++ +++ ++/+++ ++/+++ +/++ ++/+++ ++ + + +/++
15. +++/++++ +++ +++ ++/+++ +++ +++ ++ +/++ ++/+++ + ++ +/++
16. +++/++++ +++/++++ ++++ +++ +++ +++ ++/+++ ++ +++ + ++/+++ ++
17. +/++ +/++ +++ +++ +++ +++ ++/+++ ++ ++/+++ + ++/+++ ++
18. + ++ ++/+++ ++/+++ +++ +++ ++ +/++ +++ + ++ +/++
19. +/++ 0/+ +++ ++ +++ ++/+++ ++/+++ ++ +++ + + ++
20. ++/+++ + /+++ ++ +++ +++ ++/+ + ++ ++/+++ +/+ +/++ ++
Mean ++/+++ ++/+++ ++/+++ ++/+++ ++/+++ ++/+++ ++ +/++ ++/+++ + +/++ +/++
Control Group
Mean ++ +/++ +/++ +/++ +++/++++ ++ +/++ +/++ +/++ + 0 +/++
Abbreviations: EP—epithelium, CT—connective tissue, IL—interleukin, TNF-α—tumor necrosis factor-alpha, IFN-γ—interferon-gamma,
0—no immunoreactive structures, 0/+—occasional immunoreactive structures, +—few immunoreactive structures, +/++—few to moderate
immunoreactive structures, ++—moderate immunoreactive structures, + /++ —moderate to numerous immunoreactive structures,
+++—numerous immunoreactive structures, +++/++++—numerous to abundant immunoreactive structures, ++++—abundant immunore-
active structures.
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Further immunohistological staining confirmed the presence of MIP-1ß positive
macrophages in the inflammatory infiltrate of CL affected individuals (Figure 8).
Overall, no gender difference was observed in the cytokine expression or distribution
in the cleft affected individuals.
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Figure 8. MIP-1ß immunoreactive macrophages located diffusely in the subepithelium of the CL
tissue in a 6-month-old child (MIP-1ß, 200×).
3.2. Statistical Analysis
Cor elation analysis f t affected group (Table 2) displays a high positive
correlation in th epithelium between IL-13 and IFN-γ.
Table 2. Correlation analysi of the cleft affected group displays positive correlations betwe n different markers in the
epithelium and connective tissue of lip specimens.
Strength of Correlation Marker 1 Marker 2 ρ p-Value
High positive correlation (ρ = 0.7–0.9) IL-13 in EP IFN-γ in EP 0.71 <0.0001
Moderate positive correlation (ρ = 0.5–0.7)
TNF-α in EP TNF-α in CT 0.647 0.002
IL-13 in EP IL-12 in EP 0.646 0.002
IL-2 in EP IL-12 in EP 0.64 0.002
IL-2 in EP IL-13 in EP 0.637 0.003
IL-2 in CT IL-12 in CT 0.635 0.003
IL-13 in CT IL-12 in CT 0.628 0.003
IL-12 in EP TNF-α in EP 0.589 0.006
IL-2 in EP IL-2 in CT 0.577 0.008
IL-7 in EP IL-12 in EP 0.514 0.02
IL-2 in EP TNF-α in EP 0.512 0.021
Abbreviations: EP—epithelium, CT—connective tissue, IL—interleukin, TNF-α—tumor necrosis factor-alpha, IFN-γ—interferon-gamma.
A moderate positive correlation was noted in the CL epithelium between IL-2 and
TNF-α, IL-2 and IL-12, IL-2 and IL-13, IL-7 and IL-12, IL-12 and TNF-α, and IL-13 and IL-12,
and in the connective tissue between IL-2 a d IL-12 as well as between IL-13 and IL-12.
Additionally, moderate positive correlation was detected between the TNF-α distribution
in the epithelium and the connective tissue.
A statistically significant difference between the marker distribution in the cleft affected
group and the control group (Table 3) was observed with IL-2 in the epithelium, IL-7 in the
epithelium, IL-12 in the epithelium and connective tissue, and IFN-γ in the epithelium.
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Table 3. Statistically significant differences between the cleft lip and palate affected group and controls.
Marker Mann–Whitney U Z-Score p-Value
IL-2 in EP 7.5 −3.3364 0.002
IL-7 in EP 9.0 −3.169 0.001
IL-12 in EP 8 −3.288 0.001
IL-12 in CT 19 −2.559 0.011
IFN-γ in EP 7.5 −2.959 0.02
Abbreviations: EP—epithelium, CT—connective tissue, IL—interleukin, IFN-γ—interferon-gamma.
4. Discussion
As an initial physical barrier, the oral mucosa provides a well-adapted defense to
an array of environmental pressures and commensal and innocuous antigens without
provoking a disproportionate inflammatory response [35]. Immunoregulatory response in
our patients favored a prominent pattern of cytokines IL-7, IL-12, and IFN-γ predominantly
in the cleft affected epithelium, seemingly indicating the specific role of those cytokines in
the protective function.
In the adaptive immune response, IFN-γ is predominantly secreted by Th1 cells [30].
No link between IFN-γ and local immune mucosal response in cleft mucosa has been
established to this point. However, we speculate that the increased levels of IFN-γ in
line with TNF-α are successors of a sustained activation of M1 macrophages, which by
themselves induce the prototypic T cell mediated chronic inflammatory response that we
observed in the cleft tissue samples. This observation is supported by the research of
others [9]. An example of T cell mediated chronic inflammatory response is oral lichen
planus (OLP) [36], in which infiltrating monocytes are recruited into oral mucosa devel-
oping a pro inflammatory M1 phenotype due to high levels of TNF-α and IFN-γ at the
lesion site. IFN-γ primed M1 macrophages are considered a major determination in aiding
progression of OLP through the activation of T cells, destruction of the basal membrane,
and exacerbating mucosal erosions [37]. In agreement with our results, erosive OLP lesions
showed a higher expression of IFN-γ in direct comparison to a healthy mucosa [29].
Elevated IL-12 expression in the cleft affected mucosa proved to be in accordance
with our hypothesis of a predominantly T-cell mediated consistent inflammatory state. It
is noteworthy that both the oral epithelium and the underlying lamina propria showed
significantly higher degrees of IL-12 expression. Previous reports on the significance of
chronic oral diseases were inconsistent. While Shaddox et al. [38,39] suggest a significant
role of IL-12 in localized aggressive periodontitis in two studies, it contrasts the findings
of others. However, IL-12 production remains essential in directing activated T-cell con-
version to a Th-1 phenotype with a high IFN-γ secretion [40]. IL-12, a product of antigen
presenting cells, and IFN-γ provide the central link in connecting the innate to the adaptive
immune response.
We suggest that, considering the elevation of both cytokines IL-12 and IFN-γ, and
given their association, that a profound interaction between T-cell and antigen present-
ing cells together with a raised activation of innate immune cells produces a persistent
chronic inflammation in the cleft oral mucosa. Interestingly, an increasingly stimulated
IL-12 production and in turn amplified Th-1 cell response, by antigen presenting cells,
especially dendritic cells, has been reported in response to oral bacterial pathogens [41].
This falls in line with previous findings of a significant increase in commensal and poten-
tially pathogenic microbial organisms in cleft affected neonates compared to their healthy
counterparts [42].
Regarding the distribution of IL-7 in the cleft affected epithelium, our findings might
indicate a possible association between epithelial proliferation and inflammation, as in-
creased levels of immunoreactive epitheliocytes were seen in lip specimens. While the role
of IL-7 in the context of the oral epithelium is not well elaborated yet, studies on chronic
inflammatory diseases indicate a link between increased IL-7 levels and inflammatory
states. Bikker et al. [43] observed increased IL-7 levels in the labial salivary glands of
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patients with primary Sjögren syndrome, as well as IL-7 induced cytokine production
of TNF-α and IL-13. Apart from possible modulating effects in persistent inflammatory
states, IL-7 is mainly recognized in the homeostasis of T cells [44]. We could not detect any
observable differences between cleft affected samples and control samples in the mean IL-7
distribution in the subepithelium. Therefore, IL-7 does not seem to be specific to the oral
subepithelial connective tissue of the cleft affected children.
Increased TNF-α and IL-12 CL connective tissue response may indicate a linkage
and common function in the development of the local tissue immunity. Reports on the
increased incidence of mucosal ulceration, gingivitis, caries and a general poor oral health
in the cleft affected [45,46] gives reason to assume that the cleft pathology exposes its
carrier in a higher degree to chronic inflammatory diseases of the oral mucosal lining. This
assumption aligns with our findings of marked elevated TNF-α levels in the cleft group
over the healthy comparison group. We suspect that the high levels of pro-inflammatory
cytokine TNF-α and the accompanying inflammatory tissue response are the result of a yet
unknown environmental trigger unique to the cleft epithelium.
TNF-α is considered a main modulator in the biological response triad of inflamma-
tion, cell proliferation, and tissue remodeling [47]. Although not yet described in cleft
pathology, an increased oral mucosal level of TNF-α has been outlined in a variety of
chronic oral inflammatory conditions, most notably in periodontitis, in which TNF-α has
been linked to ongoing soft and hard tissue destruction [48]. Consistent with a persistent
inflammatory response in CLP mucosa, a report on the expression of inflammation related
signaling molecules in healed oral mucosal scars did demonstrate TNF-α negativity in
all their observed cases [49]. Furthermore, a transient enhancement of TNF-α mediated
inflammatory response in the epithelium through synchronous upregulation of IL-1ß has
been suggested through Saperstein et al. [50]. IL-1ß is considered to induce modification of
TNF receptor expression and its subsequent shedding on the epithelial surface. IL-1 has
previously been described as a predominant cytokine in cleft affected mucosa [51].
A dominant IL-12 response in inflammatory mucosal lesion points towards a high
activation of pro-inflammatory M1 macrophage phenotype, whereas the M2 phenotype is
associated with low IL-12 levels [52]. A prolonged M1 activity is tied to adverse effects on
wound healing [53].
Interestingly, IL-2 displayed higher numbers in the epithelium of controls compared
to the cleft group. IL-2 is one of the instrumental cytokines in priming and maintaining a
cell mediated immune response. Our data showed consistent elevated levels of IL-2 over
both tissue groups. Expression in epithelium proved dominant in healthy tissue, while
subepithelial levels where higher in cleft affected tissue. Interestingly, preceding reports
reported on elevated expression of IL-2 in lesions of predominantly T-cell mediated inflam-
matory diseases [29,54]. IL-2, primarily secreted by antigen primed Th-1 cells, remains
the essential growth and differentiation factor for both subsets of Th-1 and Th-2 cells. We
suspect that the IL-2 expression in cleft tissue reflects a Th1-cell driven, predominantly
subepithelial, inflammatory reaction local to the oral mucosa. A positive correlational
analysis for other markers (TNF-α, IL-12), favoring a Th1 directed tissue response, is in
support of our theory. A local T-cell mediated inflammatory response has been previously
described in oral lichenoid reactions. However, reports alternate between a Th-1 cell and
Th-2 cell predominant pathogenetic role [29].
The main novelty of our work is the complex research on the tissue factors in the
unique age group of children before and during the milk dentition age. However, we
realize that an additional quantification of tissue markers by standardized laboratory
measurements (e.g., ELISA), would be beneficial to the purely visual evaluation of im-
munohistochemistry stained samples. The use of additional techniques remained limited by
the small sample size available. Furthermore, we acknowledge that the use of a hyperdentic
control group might pose a limitation to an opposed completely healthy mucosal specimen.
Ethical considerations, however, mandate the use of this relative control group. Due to data
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limitations, we were unable to differentiate between the syndromic and non-syndromic
nature of the clefts.
5. Conclusions
The CLP affected epithelium shows high plasticity in expressing different cytokines.
The increase of IL-7, IFN-γ, and IL-12 in the CLP epithelium suggests the stimulation
of local adaptive immune responses based on consistent inflammatory processes. The
decrease in epithelial IL-2 seems specific for the CLP affected epithelium, suggesting a
possible decrease of immune cell proliferation and differentiation. IL-13 and TNF-α are not
the most characteristic cytokines of CLP tissue, while the high positive correlation between
IL-13 and IFN-γ in chronic inflammatory circumstances proves the possible stimulation
of macrophages.
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